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Chlamydophila pneumoniae is an obligate intracellular respiratory pathogen that has been associated with 
pneumonia and chronic bronchitis, atherosclerosis, asthma and other chronic diseases in humans. 
However, C. pneumoniae is not restricted to humans, as originally thought, and can cause infections in 
several animal hosts. We isolated C. pneumoniae in cell culture from nine western barred bandicoots 
(Perameles bougainville) from Australia. The sequences of five genomic regions were determined 
including full-length sequences of the16S rRNA, ompA genes and YgeD-urk intergenic spacer and partial 
sequences of the 23S rRNA, and rpoB genes. Sequence analysis of the entire 16S rRNA and ompA genes 
from bandicoot isolates demonstrated that they were 98.2- 98.3% similar to human isolates, 94.6-99.3% 
to the equine biovar and almost identical with 99.5-99.9% similarity to the koala biovar. Comparative 
genotyping of the variable domain 4 region of the ompA gene demonstrated that bandicoot isolates 
seemed to be identical to the animal genotype that has been recently identified in human carotid plaque 
specimens. Minor sequence polymorphism observed in ompA, 16S rRNA and rpoB genes of animal 
isolates, indicating genomic diversity within C. pneumoniae, may have important implications for 
diagnostic PCR assays leading to false negative results. Forty percent of selected previously published 
species-specific PCR assays were found to have sequence variability in primer and/or probe that may 
affect their performance in detecting bandicoot isolates of C. pneumoniae, or possibly other animal and 
human strains where minor sequence polymorphisms may be present. The data of this study support the 
previous observations that C. pneumoniae is not restricted to humans and may be widespread in an animal 




Chlamydophila pneumoniae is an obligate intracellular bacterium responsible for respiratory infections 
(pneumonia and bronchitis) in adults and children, affecting up to 70% of the population worldwide at 
least once during his or her lifetime (Peeling & Brunham, 1996). Persistent C. pneumoniae infections 
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have been implicated in the development of atherosclerosis, asthma and other chronic diseases in humans 





























C. pneumoniae was initially thought to be an exclusively human pathogen. However, several studies 
demonstrated that C. pneumoniae could also cause ocular, respiratory and urogenital infections in a wide 
variety of animal species, including koalas, horses, frogs and reptiles (Berger et al., 1999; Bodetti et al., 
2002; Hotzel et al., 2001; Jacobson et al., 2004; Storey et al., 1993). Current taxonomic classification 
divides C. pneumoniae into three distinct biovars: human biovar TWAR, biovar koala and biovar equine 
(Everett et al., 1999a). The distinction was based primarily on comparative sequence analysis of the 16S 
rRNA, 23S rRNA and ompA genes and biological characteristics. Human C. pneumoniae isolates were 
found to be almost identical to each other, with only 0.1 % difference in 16S rRNA gene and 0.4% 
difference in the ompA gene. While some of the animal isolates are almost identical to human strains, the 
others seem to be genetically more diverse, with up to 6% ompA gene dissimilarity (Bodetti et al., 2002). 
 
The existence of animal strains of C. pneumoniae raises the issue of possible transmission risk to humans. 
A recent study by Cochrane et al. (2005) where animal genotypes of C. pneumoniae were identified in 
human specimens and human genotypes were detected in koalas, supports the possibility of such 
transmission. However, no cases of zoonotic C. pneumoniae infections in humans have been described so 
far. 
 
In this study, C. pneumoniae was isolated from western barred bandicoots (Perameles bougainville) in 
cell culture and characterized by sequence comparison of five genomic regions relevant for molecular 
diagnostics, including 16S rRNA, 23S rRNA, ompA and rpoB genes and ygeD-urk intergenic spacer. The 
entire ompA and 16S rRNA genes, that are frequently used in species-specific PCR-based assays (Dowell 
et al., 2001; Loens et al., 2006) were sequenced and compared to the published sequences of human and 
animal C. pneumoniae isolates. Genotyping of the bandicoot isolates was performed in the variable 































Animals. All western barred bandicoots sampled in this study were from wild populations from Bernier 
island and Dryandra, Western Australia. Thirty-seven conjunctival, nasal, throat and cloacal swab 
specimens from twenty-one animals with clinical signs of ocular and/or respiratory disease were 
examined. 
 
Isolation and propagation of Chlamydiales. Isolation and propagation of Chlamydiales was performed 
by cell culture, as previously described (Roblin et al., 1992). Briefly, swab specimens were inoculated 
onto HEp-2 cell monolayers (ATCC CCL-23) by centrifugation at 1,700 x g for 1 hour. Infected 
monolayers were then overlaid with Iscove’s DMEM medium (Sigma-Aldrich, St. Luis, MO) 
supplemented with 10% fetal calf serum (Atlanta Biologicals, Lawrenceville, GA), 20mM L-glutamine 
and 1 µg/mL of cycloheximide and incubated at 35°C for 72 hours. Up to 6 passages were performed for 
each isolate. Following incubation, inoculated HEp-2 cells were fixed in ethanol and stained for specific 
chlamydial inclusions with Pathfinder Chlamydia Confirmation System (BioRad, Hercules, CA) for 30 
min at 37oC.  
 
DNA extraction. DNA from the cultured Chlamydiales was extracted using DNeasy Tissue kit (Qiagen, 
Valencia, CA) according to the manufacturer’s protocol. Human C. pneumoniae CWL029 (ATCC VR-
1310) and TW-183 (ATCC VR-2282) grown in HEp-2 cells were used as positive control in PCR assays. 
 
Chlamydiaceae specific PCR TaqMan assay.  The TQF and TQR primers and probe targeting the 
Chlamydiaceae specific region of 23S rRNA gene were as described by Everett et al. (1999b) (Table 1). 
PCR was performed using LightCycler 2.0 (Roche, Indianapolis, IN) system with DNA Master HybProbe 
kit (Roche, Indianapolis, IN), containing FastStart Taq DNA polymerase at the following conditions: 
initial denaturation step at 95oC for 10 min, then 45 cycles of denaturation at 95oC for 5 s, annealing at 
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60oC for 10 s, and extension at 72oC for 10 s. Products amplification was analyzed by manufacturers' 




























C. pneumoniae specific PCR TaqMan assay. The primers QMOMP1, QMOMP2 and QMOMPS probe 
targeting an 85 bp C.pneumoniae specific region of the ompA gene are shown in Table 1. PCR was 
performed using the Roche system mentioned above, with predenaturation at 95oC for 10 min, then 45 
cycles of denaturation at 95oC for 5 s, annealing at 60oC for 10 s, and extension at 72oC for 10 s.  
 
16S and 23S rRNA genes signature sequencing. Amplification/sequencing primers used for 16S rRNA 
gene and 23S rRNA gene products were 16SIGF, 16SIGR, U23F and 23SIGR (Table 1). PCR was 
performed using Qiagen ProofStart DNA polymerase kit (Qiagen, Valencia, CA), with initial denaturation 
at 95oC for 5 min, then 45 cycles of denaturation at 94oC for 30 s, annealing at 60oC for 30 s, extension at 
72oC for 60 s, with a final extension for 5 min at 72oC. Following amplification, the products were 
separated by electrophoresis in 2% agarose E-gel (Invitrogen, Carlsbad, CA) and visualized by using 
ultraviolet transilluminator. PCR products were purified with QIAquick PCR Purification kit (Qiagen, 
Valencia, CA) and sequenced in both directions (GeneWiz, North Brunswick, NJ). 
 
OmpA gene sequencing. DNA fragment containing the entire ompA gene was amplified with CpompA1F 
and CpompA3R primers (Table 1). PCR was performed using ProofStart DNA polymerase kit, with 
initial denaturation step at 95oC for 5 min, then 40 cycles of denaturation at 94oC for 30 s, annealing at 
55oC for 30 s, extension at 72oC for 60 s, with a final extension for 5 min at 72oC. Following 
electrophoresis in 2% agarose E-gel. PCR products were visualized by using ultraviolet transilluminator. 
PCR products containing 1170 bp ompA gene were sequenced in both directions, with overlap, using the 
sequencing primers shown in Table 1. These primers were designed using Primer3 software 
[http://frodo.wi.mit.edu/cgi-bin/ primer3/primer3_www.cgi] (Rozen & Skaletsky, 2000). 
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16S rRNA gene sequencing. DNA region containing the entire 16S rRNA gene was amplified with 
Cp16SF and Cp16SRb primers (Table 1). PCR was performed using ProofStart DNA polymerase kit, 




























oC for 5 min, then 45 cycles of denaturation at 94oC for 30 s, annealing 
at 55oC for 30 s, extension at 72oC for 60 s, with a final extension for 5 min at 72oC. Following 
electrophoresis in 2% agarose E-gel, PCR products were visualized and purified with QIAquick PCR 
Purification kit. PCR products containing 1552 bp 16S rRNA gene were sequenced in both directions, 
with overlap, using the following primers: Cp16SF1, Cp16SR1, Cp16SF2, Cp16SR2, Cp16SF3, 
Cp16SR3, Cp16SF4 and Cp16SR4 (Table 1). The above primers were designed using Primer3 program. 
 
RpoB gene sequencing. A 733 bp section of the DNA-directed RNA polymerase beta gene (rpoB) 
containing segment matching PstI fragment (Campbell et al., 1992) was amplified using CprpoBFc and 
CprpoBRc primers (Table 1), designed using Primer3.  PCR was performed using ProofStart DNA 
polymerase kit, with initial step at 95oC for 5 min, then 45 cycles of denaturation at 94oC for 30 s, 
annealing at 55oC for 30 s, extension at 72oC for 60 s, with a final extension for 5 min at 72oC. PCR 
products were purified and sequenced in both directions using the same primer pair. 
 
YgeD-urk intergenic spacer sequencing.  A 621 bp fragment spanning YgeD-urk intergenic spacer was 
amplified and sequenced using OUT1 and OUT2 primers (Table 1). PCR was performed using ProofStart 
DNA polymerase kit at the above conditions. Prior to sequencing products were purified from 2% agarose 
E-gels with QIAquick PCR Purification kit. 
 
Sequence analysis.  The sequences were analyzed using BLAST 2 [http://www.ncbi.nlm.nih.gov/blast/ 
bl2seq/ bl2.html] (Tatusova & Madden, 1999) and compared to the Chlamydiales sequences of 16S rRNA, 
23S rRNA, rpoB and ompA genes available in GenBank, including three biovars of C. pneumoniae. C. 
pneumoniae isolates which sequences were used for comparative analysis, are shown in Table 2. 
ClustalW multiple sequence alignment was performed using MegAlign 5.0 program (DNAStar, Madison, 
WI). The sequences of the entire ompA and 16S rRNA genes, partial sequences of 23S rRNA and rpoB 
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genes and YgeD-urk intergenic spacer from bandicoot C. pneumoniae were submitted to GenBank; 





























RESULTS AND DISCUSSION 
 
This is the first report of C. pneumoniae isolated and characterized in a third affected mammalian species. 
This species, western barred bandicoots are small endangered marsupials whose natural habitat is 
currently limited to Bernier and Dorre islands of the West Coast of Australia. However, uncultured 
unspeciated Chlamydiales and C. pecorum have been previously detected in these animals by molecular 
based methods (Bodetti et al., 2003; Warren et al., 2005). 
 
Isolation and speciation. Ten swab specimens (6 ocular, 3 throat and 1 nasal) from nine western barred 
bandicoots were positive by isolation in cell culture followed by staining with family specific monoclonal 
antibody against chlamydial lipopolysaccharide. These isolates were propagated by cell culture to 103-104 
inclusion forming units (IFU)/ml and were confirmed as Chlamydiaceae by 23S rRNA gene-based PCR. 
Sequence analysis of the 16S and 23S rRNA signature sequences described by Everett et al. (1999a) 
revealed that all 10 bandicoot isolates belonged to the C. pneumoniae species and were more than 99.1% 
similar to C. pneumoniae isolates of human and animal origin, with only 1-5 bp variations. 
 
OmpA gene based PCR and sequencing. All ten bandicoot isolates were tested positive by C. 
pneumoniae specific ompA-based PCR as per originally described protocol (Apfalter et al., 2003) that 
confirmed them as C. pneumoniae. However, fluorescence signal was approximately 1.7 times lower than 
in human C. pneumoniae control as shown in Figure 1. Increase in annealing temperature resulted in 
negative fluorescence signal for all bandicoot isolates but did not affect the signal for human C. 
pneumoniae control (data not shown).  Possible sequence variation between bandicoot and human isolates 
in the area where published primers and probe meant to bind the target sequence was suspected.  
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To address this performance problem of the ompA based PCR, the entire ompA gene was amplified and 
sequenced for all isolates.  OmpA genes of all bandicoot C. pneumoniae isolates were identical to each 
other. As seen in Figure 2, nucleotide alignment of the 85 bp target region used in ompA based TaqMan 
assay did reveal one single nucleotide polymorphism (SNP) in the forward primer and two SNPs in the 
probe sequence as compared to human isolates of C. pneumoniae. Overall, the entire ompA gene sequence 
from bandicoot C. pneumoniae was found to be 98.2% and 94.6% similar to human and equine biovars, 
respectively (Table 3); and almost identical, 99.9% similarity, to koala biovar (1 bp difference). This SNP 






























16S rRNA gene sequencing. 16S rRNA gene, which is also frequently used as a target for identification 
and speciation of Chlamydiales and other bacteria, was also amplified and sequenced for all bandicoot 
isolates. All bandicoot isolates were identical to each other and very similar to human and animal C. 
pneumoniae isolates as shown in Table 3. Minor nucleotide differences in both 16S rRNA and ompA 
genes may indicate genomic diversity within animal C. pneumoniae strains, as previously suggested 
(Hotzel et al., 2001).  
 
The identification of C. pneumoniae infection in western barred bandicoots further proves that this 
species is not restricted to humans, and may exist in an animal reservoir with a possible transmission risk 
to humans. Coles et al. (2001) demonstrated that animal strains of koala biovar are able to infect and 
multiply in human respiratory cells and monocytes. Recently, Cochrane et al. (2005) identified an animal 
genotype of C. pneumoniae in carotid arteries and PBMC specimens from humans, and human genotype 
in PBMC specimens from koalas by using nested ompA- and ygeD-urk-based PCR and sequencing 
assays. The authors suggested that C. pneumoniae might be capable of being transmitted between human 
and animals. 
 
Genotyping.  Data on genotyping of human and animal strains of C. pneumoniae are limited. 
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For genotyping purposes three genomic targets were selected: variable domain 4 region (VD4) of the 





























VD4 genotyping. VD4 was proposed as a possible genotyping target due to its small size and high degree 
of variability between human and animal isolates (Cochrane et al., 2005; Wardrop et al., 1999). Bodetti et 
al. (2002) suggested a genotyping system based on as little as 1 bp sequence polymorphism in VD4 
segment of ompA gene. We analyzed C. pneumoniae VD4 sequences publicly available in the GenBank 
database and identified 22 sequences that we separated into 3 human and 7 animal genotype groups 
(based on their sequence identity within a group) as presented in Table 4. Sequence alignment of the 174 
bp region of the VD4 segment demonstrated that bandicoot isolates differed from human isolates by 6-7 
SNPs and were identical to previously reported koala and frog isolates (genotype group A5) and, 
according to the Cochrane et al. (2005) designations, would be assigned to genotype D.  Interestingly, the 
animal C. pneumoniae isolates from genotype group A1 from reptiles and amphibians (Bodetti et al., 
2002) were absolutely identical to human isolates from group H1 as shown in Figure 3. 
 
YgeD-urk genotyping. The intergenic spacer region between YgeD and urk genes differs by the 
orientation of a 23 bp segment in one of the human C. pneumoniae strains (Read et al., 2000) and was 
used for genotyping of C. pneumoniae, (Cochrane et al., 2005). The results of the 320 bp YgeD-urk spacer 
genotyping are shown in Figure 4. The bandicoot isolates were identical to CpnIII genotype recently 
found in humans (Cochrane et al., 2005) and had the 23 bp invertible region in the same orientation as 
human TW-183, AR39 and J138 strains. There was a 3 bp difference as compared to human isolates. 
 
RpoB genotyping. RpoB gene was of relevant interest because of its current use as a target in C. 
pneumoniae specific PCR assays (Dowell et al., 2001; Loens et al., 2006). Sequence analysis of the rpoB 
gene region that matched the PstI fragment (Campbell et al., 1992) showed a 1 bp polymorphism as 
compared to human strains of C. pneumoniae (Figure 5). This nucleotide change at position 2946 was a 





























C. pneumoniae species-specific PCR assays and sequence polymorphism. The results of this study 
may have important implications for molecular diagnostics of C. pneumoniae infection in both animals 
and humans. Since most of the C. pneumoniae specific PCR assays were developed and evaluated using 
human isolates, they may not be appropriate for detection of animal strains. Even minor sequence 
variability in the target regions can significantly compromise the sensitivity of the PCR assay and result 
in false negative results due either to target amplification failure (primer sequence polymorphism) or 
target detection failure (probe sequence polymorphism) (Kwok et al., 1990; Stevenson et al., 2005). As 
we demonstrated in this study a real-time ompA based PCR assay developed for human strains either 
generated a lower fluorescent signal or failed to detect bandicoot C. pneumoniae isolates because there 
was one SNP in the forward primer and two SNPs in the probe. Similar assay performance problems due 
to target sequence variability have been recently reported for real-time PCRs for detection of herpes 
simplex virus and Listeria monocytogenes (Rodriguez-Lazaro et al., 2004; Stevenson et al., 2005). We 
analyzed several published and currently used C. pneumoniae species-specific PCR assays for the 
presence of the sequence polymorphism in the target regions as shown in Table 5.  We found that 6 out of 
15 species-specific PCR assays had sequence variability in primer and/or probe that may affect their 
performance in detecting bandicoot strain of C. pneumoniae, or possibly other animal and human strains 
where minor sequence polymorphism may be present. 
 
The expanding number of animal hosts and isolates of C. pneumoniae and genetic similarity of animal 
and human strains raises some interesting questions about the evolution and epidemiology of this 
pathogen. It is quite possible that C. pneumoniae was primarily an animal pathogen, which was only 
recently, in evolutionary terms, acquired by humans. Considering almost universal exposure of humans to 
C. pneumoniae and generally inefficient mode of transmission from person to person (Blasi et al., 1998), 
one could hypothesize that an environmental source of C. pneumoniae should be in close proximity to 
humans. While possible zoonotic transmission of C. pneumoniae from exotic animals occupying a unique 
environmental niche (koalas and bandicoots) to humans seems unlikely, acquisition by contact with 
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animals living in urban or rural areas, including domestic and production animals, either directly or via a 
transmission vector such as free-living protozoa could be possible (Essig et al., 1997). However, in 
addition to the previously described equine biovar (Storey et al., 1993) there have been only two reports 
of possible C. pneumoniae infection in domesticated animals.  Sako et al. (2002) described detection of 
C. pneumoniae antigens in vascular specimens from dogs and Canderle et al. (2005) reported high 





























More targeted research efforts are necessary to determine the prevalence and host range of C. pneumoniae 
in environmental reservoirs of different geographic regions since most of the published reports on animal 
strains were simply serendipitous findings. There is also a need for development of relevant and 
consistent genotyping system to be used for epidemiological surveillance, pathogenesis, evolution studies 
and characterization of novel C. pneumoniae isolates. 
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QMOMP2  5’-GTGAACCACTCTGCATCGTGTAA-3’ 176688-176710 Real time PCR   
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CpompA1F ompA 
 


















 CpompA2F 5'-GCAGGCTTCATTGCCTTAAA-3' 176715-176734 Sequencing











5’-CGGCGTGGATGAGGCAT-3’ 96733-96749 PCR/sequencing 294
 







Cp16SF 16S rRNA 
 










5’-TGCAGGCCAGTATAAAATGC-3’ 96634-96653 Sequencing - This study
 Cp16SR1 5’-TAAGGCCTTCATCACACACG-3’ 97104-97123 Sequencing
Cp16SF2 5’-ACACTGCCCAGACTCCTACG-3’ 97028-97047 Sequencing
Cp16SR2 5’-CATCGTTTACGGCAAGGACT-3’ 97503-97522 Sequencing
Cp16SF3 5’-GAAAGCAAGGGGAGCAAAC-3’ 97466-97484 Sequencing
Cp16SR3 5’-CCATTGTAGCACGTGTGTCG-3’ 97924-97943 Sequencing




   
TQF 23S rRNA
 
5′-GAAAAGAACCCTTGTTAAGGGAG-3′ 98986-99008 Real time PCR 128  Everett et al., 1999b 












98502- 98531 PCR/sequencing 602
 







CprpoBFc rpoB 5’-CGAACTTGTAGAAGAAGCTGTTCA-3’ 94409-94432 PCR/sequencing 733  This study 
CprpoBRc 
 







OUT1 YgeD-urk spacer 
 
5'-GTTAGGGTGGTTTTCCCAGC-3' 221724-221743 PCR/sequencing 621  
 
Cochrane et al., 2005 




Table 2. C. pneumoniae sequences used for comparative analysis.  423 
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African clawed frog, CPXT1 
 
 
African frog, DE177 
 
 
Blue Mountains tree frog, tree frog type I 
 
Giant barred frog, frog Mi-1 
 
Burmese python, burmese python type I 
 
Iguana, iguana type I 
 
 
Puff adder, puff adder type I 
 
Green sea turtle, turtle type I  
 
Chameleon, chameleon type I       
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Fig. 1. Fluorescence signal of species-specific ompA-based real time PCR of bandicoot C. 
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Fig. 2. Nucleotide sequence alignment of the 85 bp ompA target region, used in C. pneumoniae specific TaqMan PCR assay. Dots indicate 
the same nucleotides as in sequences of human isolates (TW-183, CWL029, AR-39 and J138). 
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burmese python type I, iguana type I, puff adder type I, 
turtle type I, tree frog type I 
 












































TACAGACTAAACTCTTTAGTGCCATACATTGGAGTACAATGGTCTCGAGCAACTTTTGATGCTGATAACATCCGCATTGCTCAGCCA Group H1  
....................................................................................... Group H2 
....................................................................................... Group H3 
....................................................................................... Group A1 
....................................................................................... Group A2 
....................................................................................... Group A3 
.....G................................................................................. Group A4 
..T.................................................................................... Group A5 
..T.................................................................................... Group A6 
..T.....C..........................C................................................... Group A7 
 
913                                                                                 999 
.........................................................A.G...A.....C......G.......... WBB 
AAACTACCTACAGCTGTTTTAAACTTAACTGCATGGAACCCTTCTTTACTAGGAAATGCCACAGCATTGTCTACTACTGATTCGTTC Group H1 
..........................................C............................................ Group H2 
..............................................................G........................ Group H3 
....................................................................................... Group A1 
.............T......................................................................... Group A2 
...............................................................A.....C......A.......... Group A3 
...............................................................A............A.......... Group A4 
.........................................................A.G...A.....C......G.......... Group A5 
.........................................................A.G...A.....G......G.......... Group A6 
..G............A.....................................G.G.........TG.T...T.AT.....CAA... Group A7 
 
 
Fig. 3. Nucleotide sequence alignment of a 174 bp region within VD4 segment of bandicoot C. pneumoniae ompA gene with human and 
animal genotype. Dots indicate the same nucleotide as in sequences of human H1 group. GenBank accession number for WBB isolates is 
DQ358972. 
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91                                                                                     180 
.................................................................................G........ WBB 




181                                                                                    269 
..........................-............................................................... WBB  




270                                             320 
...................................................                                        WBB 
CCGCATTTTGTTGTGTGCTGATTACAAGAGAAGTACTAAGGAGAAAAATTT                                        AR39, TW-183, J138  
...................................................                                        CWL029 
..................                                                                         CpnIII 
 
Fig. 4. Nucleotide sequence alignment of a 320 bp YgeD-urk intergenic spacer of bandicoot and human isolates. Dots indicate the same 
nucleotide as in sequences of human AR39, TW-183 and J138 isolates and dashes represent gaps in the sequences. CpnIII is a                   
















2783                                                                        2862 
................................................................................ WBB 
CCATTATTCACCGTCGTACAGCAGAAATCGTTGTTCATGAAGGCCTACTCTTTGATCAAGAGACAATAGAACGGATAGAA Human* 

























                             HL-1   










3023                                                                        3101 
............-................................................................... WBB 
TCATTCGCCAAG-TTAAAGTCTACGTTGCCTCTAAGAGAAAACTTCAAGTTGGAGATAAAATGGCTGGACGACACGGAAA Human 
............G................................................................... PstI  
 
3102                                                                        3180 
.............................................................................-.. WBB 
TAAAGGTGTTGTTTCCAAAATCGTTCCCGAAGCGGATATGCCATATCTCTCTAACGGAGAAACTGTACAAATGATCC-TG Human 
.............................................................................C.. PstI  
 
3181                                                                  3253 
.......................................................-..................       WBB 
AACCCCCTCGGGGTGCCTTCAAGGATGAACCTTGGACAGGTATTAGAAACACACC-TAGGTTATGCAGCAAAAA       Human 








                                                               HR-1 
 
Fig. 5. Nucleotide sequence alignment of a 474 bp region of rpoB gene (matching PstI fragment) of human and WBB isolates. Dots 
indicate the same nucleotides as in human isolates and dashes represent gaps in the sequence. Human isolates represented by TW-183, 




Table 5. Sequence variability in the target regions of the selected species-specific PCR assays as compared to 




























































































Tondella et al., 2002 
 























































   




















































































Templeton et al., 2005 
 
 560 
561 * These assays meet CDC validation criteria (Dowell et al., 2001).  
